'We are not cheaters' says Belgian rider Shari Bossuyt after anti-doping positive
The Canyon-SRAM rider tested positive for Letrozole in an anti-doping control in March


The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Thank you for signing up to The Pick. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Belgian cyclist Shari Bossuyt has pleaded her innocence after testing positive for a banned substance, and being made “non-active” by her Canyon-SRAM team.
The 22-year-old returned a positive test for Letrozole in an anti-doping control during the Tour de Normandie Féminin in March. The substance, a hormone drug used more generally to treat breast cancer, is on the World Anti-Doping Agency’s (WADA) Prohibited List.
In a press conference on Monday, Bossuyt said she has "never consciously used" the drug, and that she believes her sample was contaminated.
"At the moment the procedure is still ongoing and I have to explain to the AFLD [the French Anti-Doping Agency] how the product ended up in my body," the Belgian is quoted in Het Laatste Nieuws. "This is turning out to be extremely difficult today because I have never come into contact with Letrozole and have never consciously used it.
"In fact, this was the first time I had heard of Letrozole. Fortunately, I am currently well supported. I hope we can clarify soon. But above all, that we can prove that we are not cheaters."
In a statement released on Sunday, Bossuyt's Canyon-SRAM team outlined that it holds a "zero-tolerance stance towards any use of prohibited substances" and that it had made the rider "provisionally non-active", effectively suspending her.
Bossuyt, too, confirmed that she will not take part in any events. "In consultation with the team, I have decided not to race in the coming weeks. Mainly because my head isn't in it," she said.
"Everything indicates that we are dealing with a contamination. That is why I would like to appeal to all authorities that we may be dealing with an underlying problem. I will continue to train so that I can compete again soon.”
The news comes over a year after another Belgian cyclist, Toon Aerts, also tested positive for Letrozole. The cyclo-cross rider, who returned an out-of-competition sample containing the banned substance in January 2022, is yet to return to racing, and has said he is facing a two-year suspension.
Aerts issued a statement on Sunday following the announcement of Bossuyt’s Letrozole positive. He said: “We are one year on, I’m still deep in misery, and unfortunately there is another case. I can imagine so well what Shari is going through now. This shouldn't happen. Another athlete, who is also human, who will go through a deep valley with her whole family. Without having done anything wrong, just like me and my family!
He added: “No two without three, as the saying goes, and I fear there will be more victims…”
Bossuyt and her Canyon-SRAM team are currently awaiting the decision from the AFLD, which will come in due course. A suspension would rule the Belgian out of defending her Madison world title, which she holds with Lotte Kopecky, at the UCI Track World Championships this August.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!

Tom joined Cycling Weekly as a news and features writer in the summer of 2022, having previously contributed as a freelancer. He is the host of The TT Podcast, which covers both the men's and women's pelotons and has featured a number of prominent British riders.
An enthusiastic cyclist himself, Tom likes it most when the road goes uphill and actively seeks out double-figure gradients on his rides.
He's also fluent in French and Spanish and holds a master's degree in International Journalism.
-
-
'The hardest ride': Matt Downie beats Mark Beaumont's NC500 record by an hour
26-year-old completes 516 mile course in 27 hours 30 minutes dead to set new best time
By Adam Becket Published
-
5 Kickstarter products to help your commute
We take a look at some of the most backed products from the Kickstarter program and beyond
By Joe Baker Published
-
Toon Aerts sends ‘big and heartfelt middle finger’ to UCI after doping suspension
29-year-old handed two-year ban last week after failing to prove innocence
By Tom Davidson Published
-
Jumbo-Visma rider Michel Hessmann suspended after positive anti-doping test
The 22-year-old's out-of-competition sample detected the presence of diuretics
By Tom Davidson Published
-
Former British Cycling doctor Richard Freeman given four-year doping ban
Freeman chose not to defend himself before the anti-doping panel
By Tom Davidson Published
-
"Failing that drug test was the best thing that had ever happened to me"
Abuse victim and disgraced cycling champion Geneviève Jeanson finds solace in return to bike racing
By Anne-Marije Rook Published
-
29 cases of alleged doping recorded in cycling in 2022, but only one at WorldTour
Most came from semi-professional ranks, MPCC finds
By Tom Davidson Published
-
From straight-A student to Zwift Academy winner: Alex Morrice on her rise to the pro ranks
The 22-year-old rode her first road race in June, now she’s gearing up to join WorldTour team Canyon-Sram
By Tom Davidson Published
-
Zwift announces Academy winners who will join pro teams in 2023
Alex Morrice and Luca Vergallito have both won pro contracts for next season
By Tom Davidson Published
-
UCI boosts anti-doping funding by 35%
Financial backing of anti-doping programme to rise by 35 percent over the next two years
By Tom Thewlis Published